Send to

Choose Destination
See comment in PubMed Commons below
Bone. 2012 May;50(5):1023-5.

Paget's disease of the bone after treatment with Denosumab: a case report.

Author information

Research Center of Ageing and Osteoporosis, Department of Medicine, Glostrup University Hospital, 2600 Glostrup, Denmark.


Bone affection in Paget's disease is characterized by increased bone turnover localised at one or more sites of the skeleton. Bisphosphonates are the drugs of choice when treating the increased bone turnover in Paget's disease. However, in cases of decreased kidney function only less effective treatments that are available as bisphosphonates are contraindicated in these patients. We present a case of a male patient aged 86 years with GFR of 11 mL/min and Paget's disease successfully treated by Denosumab. The bone turnover and pain decreased upon treatment.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center